<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects</h1>
  <ul>
<li>Wainwright reiterated a ‘Buy’ rating on the stock and a $194 price target.</li>
<li>On September 5, H.C.</li>
<li>Dapirolizumab pegol has already achieved positive Phase 3 results and is progressing into a confirmatory trial (PHOENYCS-FLY), expected to be completed in 2027 or early 2028.</li>
<li>READ NEXT: 11 Best Wind Power and Solar Stocks to Buy According to Analysts and 10 Best Robinhood Penny Stocks to Invest In.</li>
<li>Biogen Inc.</li>
<li>According to H.C.</li>
<li>Disclosure: None.</li>
</ul>
<p><a href="https://finance.yahoo.com/news/h-c-wainwright-affirms-biogen-130329189.html">Source</a> · 2025-09-15T13:03:29+00:00</p>
</body>
</html>